載入...
Multiple sclerosis management during the COVID-19 pandemic
BACKGROUND: People with multiple sclerosis (MS) may be at higher risk for complications from the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease modifying therapies (DMTs) and greater need for medical services. OBJECTIVES: To evaluate risk factors for COVID-19 susceptibil...
Na minha lista:
| 發表在: | Mult Scler |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7424611/ https://ncbi.nlm.nih.gov/pubmed/32772807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458520948231 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|